2026 Global: Autotransfusion Systems Market-Competitive Review (2032) report
Description
The 2026 Global: Autotransfusion Systems Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Haemonetics Corporation, headquartered in Braintree, Massachusetts, United States, is a leading provider of blood management solutions that include intraoperative autotransfusion and cell-salvage systems widely deployed in surgical settings. Its flagship devices enable the collection, processing, and reinfusion of salvaged patient blood, supporting reductions in allogeneic transfusion and improved workflow efficiency. Terumo Corporation, based in Tokyo, Japan, operates the Terumo BCT division, which delivers cell salvage and apheresis technologies that are frequently utilized in cardiovascular and trauma procedures. Fresenius Medical Care AG & Co. KGaA, headquartered in Bad Homburg, Germany, extends hospital blood-management programs that incorporate autotransfusion capabilities as part of comprehensive patient blood management. Getinge AB, with headquarters in Getinge, Sweden, markets the Getinge Cell Saver System alongside an extensive portfolio of surgical tables, anesthesia workstations, and perioperative care devices, reinforcing its role as a global supplier of integrated autotransfusion workflows. These firms collectively shape contemporary transfusion practice and policy.
Grifols SA, headquartered in Barcelona, Spain, has expanded its portfolio beyond plasma products to include blood-management solutions that encompass autotransfusion devices and associated disposables used in hospital settings. Macopharma SAS, based in Tournefeuille, France, specializes in transfusion technologies including intraoperative cell salvage systems and consumables designed for efficient blood recovery. B. Braun Melsungen AG, headquartered in Melsungen, Germany, integrates autotransfusion equipment into its broad line of surgical and hospital supply products, promoting streamlined workflows in the OR and perioperative environments. LivaNova PLC, headquartered in London, United Kingdom, leverages its cardiovascular device ecosystem to support autotransfusion processes in cardiothoracic surgery and related protocols, frequently collaborating with surgical teams to optimize patient blood management. These firms emphasize interoperability, data integration, and regulatory compliance, which facilitates adoption of autotransfusion technologies in modern operating rooms. Their global footprints enable training, service, and supply chain resilience across high-volume centers and emerging markets. For growth.
Nipro Corporation, headquartered in Osaka, Japan, maintains a footprint in medical devices and consumables, including intraoperative cell salvage systems and autotransfusion disposables used to support surgical blood recovery in Asia-Pacific and other regions. The company leverages its manufacturing scale and regional distribution to extend access to autotransfusion technology in developing health systems, complementing established Western suppliers. Becton, Dickinson and Company (BD), headquartered in Franklin Lakes, New Jersey, United States, offers a comprehensive suite of blood-management devices, including autotransfusion systems, that integrate with broader perioperative and transfusion workflows to support patient safety and operational efficiency. Together, these firms contribute to a landscape focused on automation, real-time data capture, and interoperability across operating rooms. Competitive dynamics depend on regulatory approvals, product quality, service networks, and scalable supply of compatible disposables. As hospitals pursue enhanced blood management, autotransfusion systems are likely to grow in routine surgeries and complex trauma cases worldwide across regions.
Haemonetics Corporation, headquartered in Braintree, Massachusetts, United States, is a leading provider of blood management solutions that include intraoperative autotransfusion and cell-salvage systems widely deployed in surgical settings. Its flagship devices enable the collection, processing, and reinfusion of salvaged patient blood, supporting reductions in allogeneic transfusion and improved workflow efficiency. Terumo Corporation, based in Tokyo, Japan, operates the Terumo BCT division, which delivers cell salvage and apheresis technologies that are frequently utilized in cardiovascular and trauma procedures. Fresenius Medical Care AG & Co. KGaA, headquartered in Bad Homburg, Germany, extends hospital blood-management programs that incorporate autotransfusion capabilities as part of comprehensive patient blood management. Getinge AB, with headquarters in Getinge, Sweden, markets the Getinge Cell Saver System alongside an extensive portfolio of surgical tables, anesthesia workstations, and perioperative care devices, reinforcing its role as a global supplier of integrated autotransfusion workflows. These firms collectively shape contemporary transfusion practice and policy.
Grifols SA, headquartered in Barcelona, Spain, has expanded its portfolio beyond plasma products to include blood-management solutions that encompass autotransfusion devices and associated disposables used in hospital settings. Macopharma SAS, based in Tournefeuille, France, specializes in transfusion technologies including intraoperative cell salvage systems and consumables designed for efficient blood recovery. B. Braun Melsungen AG, headquartered in Melsungen, Germany, integrates autotransfusion equipment into its broad line of surgical and hospital supply products, promoting streamlined workflows in the OR and perioperative environments. LivaNova PLC, headquartered in London, United Kingdom, leverages its cardiovascular device ecosystem to support autotransfusion processes in cardiothoracic surgery and related protocols, frequently collaborating with surgical teams to optimize patient blood management. These firms emphasize interoperability, data integration, and regulatory compliance, which facilitates adoption of autotransfusion technologies in modern operating rooms. Their global footprints enable training, service, and supply chain resilience across high-volume centers and emerging markets. For growth.
Nipro Corporation, headquartered in Osaka, Japan, maintains a footprint in medical devices and consumables, including intraoperative cell salvage systems and autotransfusion disposables used to support surgical blood recovery in Asia-Pacific and other regions. The company leverages its manufacturing scale and regional distribution to extend access to autotransfusion technology in developing health systems, complementing established Western suppliers. Becton, Dickinson and Company (BD), headquartered in Franklin Lakes, New Jersey, United States, offers a comprehensive suite of blood-management devices, including autotransfusion systems, that integrate with broader perioperative and transfusion workflows to support patient safety and operational efficiency. Together, these firms contribute to a landscape focused on automation, real-time data capture, and interoperability across operating rooms. Competitive dynamics depend on regulatory approvals, product quality, service networks, and scalable supply of compatible disposables. As hospitals pursue enhanced blood management, autotransfusion systems are likely to grow in routine surgeries and complex trauma cases worldwide across regions.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
